Omkar Pharmachem
BSE: 532167
₹ 6.57▼ 0.33 (−4.78%)27 Oct, 03:19 pm IST
- Market cap
- ₹ 7 Cr.
- P/E
- 73.6x
- P/B
- 0.21x
- 52-week range
- 6.57 – 29.74
- ROE
- 1%
- ROCE
- 0.7%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- BSE
About
Omkar Pharmachem Limited is an India-based company. The Company is engaged in the pharmaceuticals and chemicals business. It also provides management and business support services.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →Omkar Pharmachem against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)73.6 against a typical 22.7: pricier than most peers (1st = cheapest).59th of 72
- Sales growth−35.7% against a typical +12.7% from a year earlier.59th of 65
- Profit growth−133.3% against a typical +13.6% from a year earlier.47th of 49
- Share price, 3 months−58.9% against a typical −2.2%.65th of 65
- Size₹ 7.3 Cr. market value against a typical ₹ 131.2 Cr. (1st = largest).68th of 69
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 |
| OPM % | 64.3% | 50% | 57.1% | 35.7% | 64.3% | 64.3% | 50% | 28.6% | 50% | 36.4% | 22.2% | −11.1% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 |
| Tax % | 0% | 0% | 120% | 0% | 0% | 0% | 140% | 25% | 28.6% | 25% | 0% | 0% |
| Net Profit | 0 | 0 | −0 | 0 | 0 | 0 | −0 | 0 | 0 | 0 | 0 | −0 |
| EPS in Rs | 0.09 | 0.07 | −0.02 | 0.05 | 0.09 | 0.08 | −0.02 | 0.03 | 0.05 | 0.03 | 0.02 | −0.01 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- 12%
- 3 Years
- −5%
- TTM
- −23%
Compounded Profit Growth
- 10 Years
- 12%
- 5 Years
- −11%
- 3 Years
- −16%
- TTM
- −50%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- −11%
- 3 Years
- −18%
- TTM
- —
Return on Equity
- 10 Years
- 0%
- 5 Years
- 2%
- 3 Years
- 1%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 73.6xEPS (12 months) ₹ 0.09Median P/E 122.1x
P/E (times)EPS (₹)
Peers
Listed companies in the same business.
| Omkar Pharmachem | ₹ 6.57 | ₹ 7 Cr. | 73.6x | 0.2x | 1% | — |
| REC | ₹ 293.65 | ₹ 77,325 Cr. | 5.2x | 1x | — | 27.1% |
| Altius Telecom Infrastructure Trust | ₹ 170.00 | ₹ 0 Cr. | 47.5x | 4.6x | — | 4.8% |
| National Highways Infra Trust | ₹ 168.00 | ₹ 35,928 Cr. | 47.6x | 1.5x | 3% | 16% |
| IndiGrid Infrastructure Trust | ₹ 164.83 | ₹ 15,701 Cr. | 37.3x | 2.8x | 7% | 8.4% |
| Indus Infra Trust | ₹ 124.00 | ₹ 7,576 Cr. | 15.5x | 1.3x | — | 56.5% |
Management
- Arun Kumar
- Chief Financial Officer
- Pankaj Mahadeo Singh
- Compliance Officer, Company Secretary
- Bhawani Shankar Goyal
- Managing Director, Additional Director
Prices are delayed and for information only. Nothing on this page is investment advice.